There, sNFL (the authors measured plasma NFL, which is comparable to sNFL) dichotomized to “low” (<30 pg/mL) and “high” (≥30 pg/mL) has significant predictive value to identify patients at risk of MS progression. The gene discussed is NEFL; the disease is myeloid sarcoma.